SITC COVID-19 Resources

The coronavirus (COVID-19) pandemic has affected all aspects of healthcare and the oncology and immuno-oncology communities may face unique challenges in regards to patient care. As immuno-oncology practitioners treat patients during the pandemic, it has also become apparent that the immunotherapy field may offer important insights into clinical practice, immune-related pathophysiology and other topics that may be useful to the broader healthcare community during this time of great need. 

SITC is committed to providing the most current COVID-19 information and resources to its members and the oncology community at large. 
Resources will be updated on a regular basis throughout this rapidly evolving situation. Please continue to check back for the most current information.


SITC Statements and Publications

SITC Statement on anti-IL-6/IL-6R for COVID-19
To support clinicians working at the front lines of the COVID-19 pandemic, the Society for Immunotherapy of Cancer (SITC) is advocating for the pharmaceutical industry, health authorities and institutional IRBs to continue to work creatively and collaboratively to expand access to IL-6-targeting therapies for their potential use in critically-ill patients with COVID-19.

Read More >>


SITC Advocates for Scientific Journals to Grant Open Access for COVID-19 Publications
The Society for Immunotherapy of Cancer (SITC) has issued a call for all COVID-19-related research to be made open-access across all biomedical journals, to further facilitate exchange of information during the Coronavirus pandemic.


Read More >>


COVID-19 Discussion Forums

SITC has launched two new online communities to serve as discussion forums to facilitate global communication and rapidly disseminate critical information related to COVID-19. These forums aim to spark conversations between professionals on the frontlines of this pandemic—to facilitate the sharing of observations and insights in real time during the pandemic.

You need not be a SITC member to access and post in these discussion forums; all are encouraged to participate. Simply create a free CONNECT online account when prompted.


COVID-19 Implications for Patient Management Forum

Access the Discussion

Purpose: Conversations directly relevant to patient care

Audience:
Practicing clinicians and staff, clinical investigators


Suggested topics:
 Demographics, clinical presentation, diagnostic testing, patient management issues/insights, patterns in clinical complications, difficult cases


COVID-19 Considerations for Basic and Translational Research Forum

ACCESS THE DISCUSSION

Purpose: Conversations directly relevant to research

Audience: Laboratory and translational scientists

Suggested topics: Data sharing, emerging literature, sample/tissue collection, model/reagent development, opportunities for collaboration, translational insights, research hypotheses